Vaxcellbio signs MoU with Seoul National University for macular degeneration treatment

Vaxcellbio, a South Korea-based immuno-oncology company, has entered into a strategic Memorandum of Understanding (MoU) ...

November 14, 2025 | Friday | News
Kaigene partners with Celltrion for novel antibody therapeutics in autoimmune diseases for $736 M

Kaigene Inc., a US-based biotechnology startup pioneering next-generation antibody therapeutics for autoimmune disorders...

November 12, 2025 | Wednesday | News
Samsung Epis Holdings establishes new subsidiary to advance next-gen biotechnology platforms

South Korea-based Samsung Epis Holdings Co. has announced the establishment of Epis NexLab Co., a new subsidiary that wi...

November 11, 2025 | Tuesday | News
Singapore, Korea researchers harness AI to tackle male infertility

Researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and CHA Univ...

November 10, 2025 | Monday | News
Omron invests in South Korean healthcare startup Sky Labs

South Korea-based healthcare startup Sky Labs has attracted investments with OMRON Ventures, Omron Group's ent...

November 6, 2025 | Thursday | News
Korea's Samsung Bioepis gains full rights to BYOOVIZ biosimilar from Biogen in Europe

South Korea-based Samsung Bioepis has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioep...

November 3, 2025 | Monday | News
Korea's SK pharmteco and LOTTE BIOLOGICS partner to strengthen global ADC CDMO capabilities

South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...

October 30, 2025 | Thursday | News
IASO Bio partners with GC Cell to bring CAR-T therapy to Korea

Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecab...

October 31, 2025 | Friday | News
Korea announces 5th Comprehensive Plan for high-tech medical complexes

The Ministry of Health and Welfare, South Korea government, has announced the the launch of the 5th Comprehensive Plan f...

October 27, 2025 | Monday | News
SK Biopharma launches JV with Eurofarma for AI-based epilepsy management platform

South Korea-based SK Biopharmaceuticals has announced the establishment of Mentis Care, Inc., a joint venture (JV) with ...

October 23, 2025 | Thursday | News
Chinese startup Phrontline Biopharma joins hands with Samsung Bioepis to co-develop ADC assets

South Korea-based Samsung Bioepis Co., Ltd. and Chinese startup Phrontline Biopharma, a clinical-stage biotechnology com...

October 21, 2025 | Tuesday | News
Samsung partners with Grail in $110 M deal to expand early cancer testing across Asia

South Korea's Samsung C&T (SCT), Samsung Electronics (SEC), and US-based GRAIL, Inc. have signed a binding Letter of...

October 21, 2025 | Tuesday | News
Boehringer Ingelheim inks $991 M deal with Korea's AimedBio for cancer antibody-drug conjugate portfolio

Germany's Boehringer Ingelheim and Korean biotech startup AimedBio have announced a global collaboration and licensing a...

October 17, 2025 | Friday | News
Texas Medical Center unveils BioBridge with Republic of Korea

A new collaboration between Texas Medical Center, the world’s largest innovation hub, and the Osong Medical Innova...

October 16, 2025 | Thursday | News
South Korea selects PacBio HiFi Technology for National Pangenome Project

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced that its HiFi sequencin...

October 14, 2025 | Tuesday | News
Korea's GC Biopharma secures contract manufacturing rights for Shingles vaccine from Curevo

GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...

October 13, 2025 | Monday | News
Korea's Samsung Biologics introduces optimised manufacturing framework ExellenS™

South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...

October 10, 2025 | Friday | News
Rentschler Biopharma further expands services in Japan and South Korea

Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...

October 8, 2025 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls